Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report Ayako YamazakiYasuhito AraiSumihito Nobusawa Case Report 21 May 2022 Pages: 171 - 178
T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings Shinji YamashitaHideo TakeshimaKiyotaka Yokogami Original Article 28 April 2022 Pages: 88 - 98
Preface for Brain Tumor Pathology vol. 39 issue 2 Hideo Takeshima Preface 08 April 2022 Pages: 45 - 46
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma Yoshihiro OtaniJi Young YooBalveen Kaur Review Article 06 April 2022 Pages: 57 - 64
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation Yukitomo IshiShigeru YamaguchiMiki Fujimura Original Article 01 April 2022 Pages: 162 - 170
Ribosomal proteins induce stem cell-like characteristics in glioma cells as an “extra-ribosomal function” Takuichiro HideIchiyo ShibaharaToshihiro Kumabe Review Article 05 May 2022 Pages: 51 - 56
Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications Dheeraj ChinnamKirti GuptaBishan Dass Radotra Original Article 29 March 2022 Pages: 151 - 161
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles Takashi Komori Editorial 22 March 2022 Pages: 47 - 50
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group Kenichiro AsanoYoji YamashitaTeiji Tominaga Original Article 21 March 2022 Pages: 139 - 150
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas Eriel Sandika PareiraMakoto ShibuyaHikaru Sasaki Original Article 15 March 2022 Pages: 79 - 87
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas Hideyuki AritaKoichi Ichimura Review Article 31 January 2022 Pages: 121 - 129
Emerging glioneuronal and neuronal tumors: case-based review So Dug LimSeong Ik KimSung-Hye Park Review Article 20 January 2022 Pages: 65 - 78
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis Min-Sung KimSe-Woong ChunYong Hwy Kim Original Article 15 January 2022 Pages: 99 - 110
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature Theo F. J. KrausChristoph SchwartzKarl Sotlar Case Report Open access 11 January 2022 Pages: 111 - 119
Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors Eita UchidaAtsushi SasakiRyo Nishikawa Original Article 09 January 2022 Pages: 130 - 138
Timing of H3K27me3 loss in secondary anaplastic meningiomas Serena AmmendolaValeria Barresi Letter to the Editor 06 January 2022 Pages: 179 - 181
Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature Shefali ChopraNolan MaloneyWei Lien Wang Correction 04 January 2022 Pages: 43 - 43
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas Tomohide NishikawaReiko WatanabeIchiro Ito Original Article 26 November 2021 Pages: 14 - 24
Molecular subtyping of ependymoma and prognostic impact of Ki-67 Ka Young LimKwanghoon LeeSung-Hye Park Original Article Open access 23 November 2021 Pages: 1 - 13
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement Shino MagakiRadha SatyadevJonathan W. Said Case Report Open access 18 November 2021 Pages: 25 - 34
Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature Shefali ChopraNolan MaloneyWei Lien Wang Case Report 06 November 2021 Pages: 35 - 42
Insights in primary central nervous system lymphoma: a role for glymphatics? Ashwin Kumaria Letter to the Editor 17 September 2021 Pages: 290 - 291
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma Seong-Ik KimKwanghoon LeeJae-Kyung Won Original Article 02 August 2021 Pages: 271 - 282
Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report Takeyoshi TsutsuiYoshiki ArakawaSusumu Miyamoto Case Report 27 July 2021 Pages: 283 - 289
Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma Yoshinari OsadaRyuta SaitoTeiji Tominaga Original Article 16 July 2021 Pages: 218 - 227
Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms Chie InomotoShigeyuki TaharaRobert Y. Osamura Review Article 16 July 2021 Pages: 183 - 188
Clinical implications of molecular analysis in diffuse glioma stratification Masahiro MizoguchiNobuhiro HataToru Iwaki Original Article 15 July 2021 Pages: 210 - 217
Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development Kensuke TateishiYohei MiyakeTetsuya Yamamoto Review Article 13 July 2021 Pages: 173 - 182
Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia Weiqi DangJingfang XiaoXiuwu Bian Original Article 06 July 2021 Pages: 189 - 200
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features Manabu NatsumedaMichael ChangKarisa C. Schreck Original Article 03 July 2021 Pages: 228 - 233
Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes Zhicen LiYifan WeiJian Gong Original Article 28 June 2021 Pages: 234 - 242
Metabolic, immunohistochemical, and genetic profiling of a cerebellar liponeurocytoma with spinal dissemination: a case report and review of the literature Seiichiro HironoYue GaoYasuo Iwadate Case Report 17 June 2021 Pages: 257 - 262
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma Jun-ichi AdachiMitsuaki ShirahataRyo Nishikawa Original Article 14 June 2021 Pages: 201 - 209
Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy Eiichi IshikawaTsubasa MiyazakiHiroyoshi Akutsu Review Article 11 May 2021 Pages: 149 - 155
Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence Masaki UjiharaKazuhiko MishimaRyo Nishikawa Case Report 28 April 2021 Pages: 243 - 249
Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options Chaoying QinMeng HuangQing Liu Review Article 26 April 2021 Pages: 156 - 172
A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication Taku UchiyamaAkira GomiKensuke Kawai Case Report 09 April 2021 Pages: 250 - 256
A case of central nervous system lesion pathologically characterized by angiocentric, T-cell-rich lymphoid cell infiltrates: a case report and literature review Ryotaro ImaiHanako TsujikawaHikaru Sasaki Case Report 30 March 2021 Pages: 263 - 270
Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children’s Cancer Group Hiroaki MiyaharaManabu NatsumedaYasushi Iwasaki Original Article 11 March 2021 Pages: 109 - 121
Aberrant expression of thyroid transcription factor-1 in meningeal solitary fibrous tumor/hemangiopericytoma Haibo WuJun DuWei Wang Original Article 05 March 2021 Pages: 122 - 131
Concomitant KIAA1549-BRAF fusion and IDH mutation in Pediatric spinal cord astrocytoma: a case report and literature review Mengxue SunLeiming WangYueshan Piao Case Report 28 February 2021 Pages: 132 - 137
Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma M. Adelita VizcainoCaterina GianniniRachael Vaubel Case Report 12 January 2021 Pages: 138 - 144
The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas Manubhai KPAnurag KumarSanjeeva Srivastava Original Article 12 January 2021 Pages: 96 - 108
Correction to: EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations Aruna NambirajanAgrima SharmaMehar Chand Sharma Correction 09 January 2021 Pages: 145 - 145
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis Satoshi NakasuYoko Nakasu Review Article 06 January 2021 Pages: 81 - 95
The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system Takashi Komori Editorial 05 January 2021 Pages: 1 - 3
Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features Sho TamaiYoshiko NakanoMitsutoshi Nakada Case Report 22 November 2020 Pages: 64 - 70
EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations Aruna NambirajanAgrima SharmaMehar Chand Sharma Original Article 01 November 2020 Pages: 30 - 40
Genetic characterization of an aggressive optic nerve pilocytic glioma Christopher S. HongGreg FlineyS. Bulent Omay Case Report 24 October 2020 Pages: 59 - 63
